Analysed VIR BIOTECHNOLOGY INC (VIR:NASDAQ) News Sources
Vir Biotechnology's Chairman of the Board Sold 22,000 Company Shares. Here's What That Means for Investors.
09-05-2026
fool.com
A Look At Vir Biotechnology (VIR) Valuation After The Astellas Partnership And Pipeline Progress
10-05-2026
yahoo.com
Results: Vir Biotechnology, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
11-05-2026
yahoo.com
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
17-05-2026
fool.com
Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million
18-05-2026
fool.com
Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
18-05-2026
yahoo.com
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
23-05-2026
fool.com
How SOLSTICE Phase 2 HDV Data at Vir Biotechnology (VIR) Has Changed Its Investment Story
24-05-2026
yahoo.com
What is the current price of VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The current price of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is $8.61.
VIR BIOTECHNOLOGY INC (VIR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) since the previous trading day is $0.09.
VIR BIOTECHNOLOGY INC (VIR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) since the previous trading day is 1.0563%.
What is the most recent average sentiment score for VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The most recent average sentiment score for VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The most recent sentiment for VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is .
SEC-8K** Filing Available For VIR BIOTECHNOLOGY INC (VIR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.